Brian Colwell Jensen MD
Heart Failure & Transplantation
Professor of Medicine and Pharmacology, UNC School of Medicine
Join to view full profile
160 Dental Circle, CB 7075Chapel Hill, NC 27599
Phone+1 919-966-5202
Dr. Jensen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Brian Jensen, MD, based in Chapel Hill, NC, is a cardiologist specializing in heart failure and transplantation. Dr. Jensen obtained his medical degree from the University of North Carolina at Chapel Hill School of Medicine in 2001. He completed a cardiovascular disease fellowship at the University of California, San Francisco, and an internal medicine residency at Brigham and Women's Hospital. He is an Advanced Heart Failure cardiologist and director of the UNC Cardio-oncology clinic. His basic and translational research program focuses on the molecular and pathophysiological basis of heart failure.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 2004 - 2008
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
University of North Carolina at Chapel Hill School of MedicineClass of 2001
Certifications & Licensure
NC State Medical License 2009 - 2027
CA State Medical License 2004 - 2009
MA State Medical License 2003 - 2006
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification WebCIS, UNC Health Care, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- The nuclear receptor ROR-alpha is a putative novel myogenic regulator of the cardiomyocyte transcriptome, including the alpha-1A adrenergic receptor.Raghu Sundaresan Nagalingam, Ju Youn Beak, Richard D Lutze, Wei Huang, Dhiren Akkina
American Journal of Physiology. Heart and Circulatory Physiology. 2026-08-01 - The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart.Kelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, Ju Youn Beak, Mansi Goyal
Science Advances. 2026-07-10 - 2 citationsGenetic determinants of heart failure susceptibility and response in the collaborative cross mouse population.Todd H Kimball, Anh N Luu, Brian Gural, Caitlin Lahue, Abigail Hockett
Genetics. 2026-05-06
Press Mentions
Amyloid Also Accumulates in Heart in Alzheimer'sNovember 28th, 2016
Grant Support
- Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicityUNIV OF NORTH CAROLINA CHAPEL HILL2023–2027
- Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activationUNIV OF NORTH CAROLINA CHAPEL HILL2017–2027
- Alpha-1-Adrenergic Receptor Subtypes In The Cells Of The Human HeartNational Heart, Lung, And Blood Institute2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
